Skip to main content
Clinical Trials/IRCT20181030041503N1
IRCT20181030041503N1
Recruiting
未知

Clinical trial comparing pregnancy rate in transfer of blastocyst vs cleavage stage in assisted reproductive technology

Mashhad University of Medical Sciences0 sites220 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
220
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Uterine with normal cavity
  • Normal res ponder to ovarian stimulation
  • There are at least 5 fresh embryo
  • Sufficient thickness of endometrium in day 12 cycles

Exclusion Criteria

  • lack of embryo with good quality
  • Endocrine disorder(Hypothyroidism ,diabetes)
  • Poor respond er(less and equal 3 oocyte)
  • Excessive responder to ovarian stimulation (more than 20oocyte)
  • Freeze all of all embryos
  • Refusal to cooperation in the study
  • previous surgery of uterine
  • Recurrent abortion
  • Sever male factor

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparison of pregnancy rate between fresh and frozen embryo transfer cycles in women with endometriosisEndometriosis of ovary.Endometriosis of ovary
IRCT201608171141N21Royan Institute60
Active, not recruiting
Not Applicable
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2013-001105-81-BGActavis Group PTC ehf.766
Active, not recruiting
Phase 1
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2013-001105-81-CZActavis Group PTC ehf.766
Active, not recruiting
Not Applicable
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.
EUCTR2013-001105-81-HUActavis Group PTC ehf.766
Active, not recruiting
Phase 1
Clinical Study to compare the effect of two different vaginal application forms of the hormone progesterone (Cyclogest® Pessary and Crinone® 8% Gel) on pregnancy rates after artificial fertilization.uteal phase support after IVFTherapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
EUCTR2013-001105-81-BEActavis Group PTC ehf.766